"Orlando Health UF Health Cancer Center - Lake Mary provides expert cancer care in a convenient, community-based location. Patients in the Lake Mary and Seminole County communities can access advanced, personalized cancer treatment from a diverse team of specialists that are part of the only Cancer Center of Excellence in Central Florida. Our services include medical oncology and radiation oncology appointments, as well as chemotherapy treatments and laboratory and diagnostic services. Orlando Health UF Health Cancer Center - Lake Mary also provides cancer support services, including nutritionists, support groups and counselors."

During the past decade, Orlando Health Cancer Institute conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 110 clinical trials were completed, i.e. on average, 98.2% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 60 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Health Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "Children's Oncology Group" with 36 trials sponsored, "NRG Oncology" with 11 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Health Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Health Cancer Institute" are "Breast Cancer" (14 trials), "Melanoma" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials). Many other conditions were trialed in "Orlando Health Cancer Institute" in a lesser frequency.

Most popular intervention types in "Orlando Health Cancer Institute" are "Drug" (189 trials), "Other" (117 trials), "Biological" (80 trials), "Radiation" (60 trials) and "Procedure" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (69 trials), "Quality-of-Life Assessment" (47 trials), "Cisplatin" (29 trials), "Carboplatin" (27 trials) and "Cyclophosphamide" (25 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Health Cancer Institute" are 196 trials for "All" genders, 44 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Orlando Health Cancer Institute". undefined are not yet recruiting, 42 are recruiting, 98 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Orlando Health Cancer Institute, 5 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Health Cancer Institute, 18 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 133 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".